Lv31
276 积分 2024-03-31 加入
Multi-organ immune-related adverse events from immune checkpoint inhibitors and their downstream implications: a retrospective multicohort study
8小时前
已完结
Sunvozertinib for patients in China with platinum-pretreated locally advanced or metastatic non-small-cell lung cancer and EGFR exon 20 insertion mutation (WU-KONG6): single-arm, open-label, multicentre, phase 2 trial
2个月前
已完结
Uncommon EGFR mutations in advanced non-small cell lung cancer
2个月前
已完结
Capecitabine as Maintenance Therapy for High-Risk, Resected Colorectal Cancer
2个月前
已完结
Phase II study of short-course capecitabine plus oxaliplatin (XELOX) followed by maintenance capecitabine in advanced colorectal cancer: XelQuali study
2个月前
已完结
Maintenance treatment in metastatic colorectal cancer: in search of the best strategy
2个月前
已完结
Capecitabine maintenance therapy in metastatic colorectal cancer patients with no evidence of disease: CAMCO trial
2个月前
已完结
Maintenance treatment with oral anticancer agents after first-line chemotherapy in patients with recurrent or metastatic nasopharyngeal carcinoma: a systematic review and meta-analysis
2个月前
已完结
Cadonilimab: First Approval
2个月前
已完结
Safety and antitumour activity of cadonilimab, an anti-PD-1/CTLA-4 bispecific antibody, for patients with advanced solid tumours (COMPASSION-03): a multicentre, open-label, phase 1b/2 trial
2个月前
已完结
皖公网安备34019202002308
